SUMMARY The substrate specificity of tonin from rat submaxillary gland was examined with a series of synthetic peptides encompassing the C-terminus of the decapeptide substrate angiotensin I. In contrast to angioteosin I-converting enzyme from plasma or lung, only angiotensin I, (des-Asp')-angiotensin I, and ( IN RECENT reports 1 -* the identification and partial purification of an angiotensin I-converting enzyme from rat submaxillary gland was described. The enzyme, for which the name tonin has been suggested, 2 has recently been purified to homogeneity. 3 The subsequent enzymatic characterization revealed major differences between tonin and the classic angiotensin I-converting enzyme found in plasma, lung, and other tissues. 4 Compared to angiotensin I-converting enzyme, tonin has a much lower molecular weight of only 28,700, a different pH optimum (pH 6.5-7.2), and no chloride requirement for enzymatic activity. The inhibitors of angiotensin I-converting enzyme, ethylenediaminetetraacetic acid (EDTA), dipyridyl, and the pentapeptide Pyr-LysTrp-Ala-Pro have no effect on tonin which, on the other hand, is strongly inhibited by a plasma component. In contrast to the classic converting enzyme, tonin is devoid of kininase II activity. Preliminary studies with the frequently used tripeptide substrates of angiotensin I-converting enzyme showed that these compounds are very poor substrates of tonin. However, it was found that tonin can form angiotensin II directly from renin tetradecapeptide substrate by cleavage of the Phe-His bond. On the basis of the suspected high specificity of the enzyme and the presence of a strong plasma protein inhibitor, it has been suggested that tonin may play an important role in the local generation of angiotensin II in tissue. 1 The purpose of this study was to further elucidate the substrate specificity of tonin by use of a series of synthetic polypeptides related to the C-terminus of angiotensin I. One of these peptides, (des-Asp^angiotensin I, is of particular interest as a substrate for possible conversion to (des-Asp 1 )-angiotensin II (angiotensin III) which recently has been